News
TGA, CE Mark clearance for A.I. Solution FerriSmart
- 11 July 2018
Resonance Health is pleased to announce that FerriSmart®, its groundbreaking AI solution for the quantification of liver iron concentration (LIC), has now achieved TGA and CE Mark clearance, making it the only regulatory approved artificial intelligence tool for use in liver iron quantification.
Alliance Partner Agreement with Blackford Analysis
- 05 July 2018
Resonance Health is pleased to announce today that it has signed an Alliance Partner Agreement with Blackford Analysis.
Resonance Health News - June 2018
- 29 June 2018
Resonance Health is delighted to provide you with our latest quarterly newsletter where you can find an update on all our latest acitvities.
To read the newsletter please click here
Resonance announces Deal to distribute Diabetic Retinopathy AI tool
- 04 May 2018
Resonance Health is pleased to announce today that it has signed an agency agreement to distribute an Artificial Intelligence (AI) Diabetic Retinopathy (DR) grading tool. The contract is for a 2 year period, renewable based on performance and written agreement.
Resonance Health News - March 2018
- 23 March 2018
Resonance Health is delighted to provide you with our latest quarterly newsletter where you can find an update on all our latest acitvities.
To read the newsletter please click here
Resonance Health appoints new Non-Executive Director
- 01 March 2018
Resonance Health advises that it has appointed Mr. Mitchell Wells as a Non-Executive Director of the Company.